FDA Inspection
Dhaliwal Pharmaceuticals Laboratories, LLCDhaliwal Pharmaceuticals Laboratories, LLC – FDA Inspection, Sep 16, 2026
Record Details
This FDA Inspection record concerns Dhaliwal Pharmaceuticals Laboratories, LLC, with an inspection on September 16, 2026, issued by the Dallas District Office, covering human drugs.
- Inspection Date
- September 16, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 995950bd-0c08-4e96-83ae-3b8e535c47dd
Inspection Facts
- Inspection number
- 1336074
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.84(d)(2)Component written specification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dhaliwal Pharmaceuticals Laboratories, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dhaliwal Pharmaceuticals Laboratories, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.